Hydroxyurea
DrugBank ID: DB01005
Summary
| Metric | Value |
|---|---|
| Total Predictions | 65 |
| KG+DL (Dual Validated) | 9 |
| DL Only | 41 |
| KG Only | 15 |
Predictions
| Indication | Score | Source |
|---|---|---|
| female breast carcinoma | 0.9997 | DL |
| primary non-gestational choriocarcinoma of ovary | 0.9980 | KG+DL |
| hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | 0.9967 | DL |
| sickle cell-beta-thalassemia disease syndrome | 0.9967 | DL |
| sickle cell-hemoglobin E disease syndrome | 0.9967 | DL |
| sickle cell-hemoglobin c disease syndrome | 0.9967 | DL |
| sickle cell-hemoglobin d disease syndrome | 0.9967 | DL |
| hereditary breast ovarian cancer syndrome | 0.9961 | DL |
| ovarian mucinous adenocarcinoma | 0.9951 | KG+DL |
| ovarian clear cell adenocarcinoma | 0.9947 | KG+DL |
| cervical adenosarcoma | 0.9940 | DL |
| colon mucinous adenocarcinoma | 0.9932 | DL |
| rectum mucinous adenocarcinoma | 0.9931 | DL |
| gallbladder mucinous adenocarcinoma | 0.9928 | DL |
| cervical carcinosarcoma | 0.9926 | DL |
| ovarian endometrioid adenocarcinoma | 0.9926 | KG+DL |
| cervical mucinous adenocarcinoma | 0.9925 | DL |
| Ehrlich tumor carcinoma | 0.9924 | DL |
| estrogen-receptor positive breast cancer | 0.9924 | DL |
| hormone-resistant breast carcinoma | 0.9924 | DL |
| estrogen-receptor negative breast cancer | 0.9924 | DL |
| extrahepatic bile duct mucinous adenocarcinoma | 0.9923 | DL |
| lung colloid adenocarcinoma | 0.9921 | DL |
| ovarian cystadenocarcinoma | 0.9920 | DL |
| yolk sac tumor | 0.9918 | KG+DL |
| nipple carcinoma | 0.9916 | DL |
| maligant granulosa cell tumor of ovary | 0.9915 | KG+DL |
| breast carcinoma by gene expression profile | 0.9915 | DL |
| endometrial mucinous adenocarcinoma | 0.9915 | DL |
| rete ovarii adenocarcinoma | 0.9913 | DL |
| bilateral breast carcinoma | 0.9912 | DL |
| Krukenberg carcinoma | 0.9911 | DL |
| relapsing-remitting multiple sclerosis | 0.9908 | DL |
| ovarian small cell carcinoma | 0.9903 | KG+DL |
| malignant tumor of meninges | 0.9900 | DL |
| endometrial mixed adenocarcinoma | 0.9900 | DL |
| villoglandular endometrial endometrioid adenocarcinoma | 0.9900 | DL |
| malignant germ cell tumor of ovary | 0.9900 | KG+DL |
| mucin-rich endometrial endometrioid adenocarcinoma | 0.9893 | DL |
| secretory uterine corpus endometrioid adenocarcinoma | 0.9893 | DL |
| spinal cord cancer | 0.9890 | DL |
| adult germ cell tumor | 0.9889 | DL |
| stage I endometrioid carcinoma | 0.9884 | DL |
| stage II endometrioid carcinoma | 0.9884 | DL |
| cerebral neuroblastoma | 0.9882 | DL |
| malignant non-dysgerminomatous germ cell tumor of ovary | 0.9880 | KG+DL |
| childhood brain germinoma | 0.9880 | DL |
| cerebellopontine angle embryonal tumor | 0.9877 | DL |
| mediastinal malignant germ cell tumor | 0.9875 | DL |
| testicular yolk sac tumor, macrocystic pattern | 0.9872 | DL |
Showing top 50 of 65 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.